166 related articles for article (PubMed ID: 17052804)
1. PPAR-gamma Pro12Ala genotype and risk of cognitive decline in elders.
Yaffe K; Kanaya AM; Lindquist K; Hsueh WC; Cummings SR; Beamer B; Newman A; Rosano C; Li R; Harris T;
Neurobiol Aging; 2008 Jan; 29(1):78-83. PubMed ID: 17052804
[TBL] [Abstract][Full Text] [Related]
2. Cognitive decline and the PPAR-γ Pro12Ala genotype: variation by sex and ethnicity.
West NA; Baxter J; Bryant LL; Nelson TL
Age Ageing; 2017 Jan; 46(1):96-100. PubMed ID: 28181642
[TBL] [Abstract][Full Text] [Related]
3. The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity.
West NA; Tingle JV; Simino J; Selvin E; Bressler J; Mosley TH
Alzheimer Dis Assoc Disord; 2018; 32(2):131-136. PubMed ID: 29116943
[TBL] [Abstract][Full Text] [Related]
4. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
[TBL] [Abstract][Full Text] [Related]
5. PPARG Pro12Ala genotype and risk of cognitive decline in elders? Maybe with diabetes.
Johnson W; Harris SE; Starr JM; Whalley LJ; Deary IJ
Neurosci Lett; 2008 Mar; 434(1):50-5. PubMed ID: 18280041
[TBL] [Abstract][Full Text] [Related]
6. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Franks PW; Jablonski KA; Delahanty L; Hanson RL; Kahn SE; Altshuler D; Knowler WC; Florez JC;
Diabetologia; 2007 Dec; 50(12):2451-60. PubMed ID: 17898990
[TBL] [Abstract][Full Text] [Related]
7. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
De Cosmo S; Motterlini N; Prudente S; Pellegrini F; Trevisan R; Bossi A; Remuzzi G; Trischitta V; Ruggenenti P;
Diabetes; 2009 Dec; 58(12):2920-9. PubMed ID: 19720797
[TBL] [Abstract][Full Text] [Related]
8. Inverse effects of the PPAR(gamma)2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and whites. The CARDIA study.
Fornage M; Jacobs DR; Steffes MW; Gross MD; Bray MS; Schreiner PJ
Metabolism; 2005 Jul; 54(7):910-7. PubMed ID: 15988700
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end product level, diabetes, and accelerated cognitive aging.
Yaffe K; Lindquist K; Schwartz AV; Vitartas C; Vittinghoff E; Satterfield S; Simonsick EM; Launer L; Rosano C; Cauley JA; Harris T
Neurology; 2011 Oct; 77(14):1351-6. PubMed ID: 21900628
[TBL] [Abstract][Full Text] [Related]
10. Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population.
Li L; Cheng LX; Nsenga R; He MA; Wu TC
Clin Cardiol; 2006 Jul; 29(7):300-4. PubMed ID: 16881538
[TBL] [Abstract][Full Text] [Related]
11. THE ROLE OF PRO12ALA POLYMORPHISM OF THE PPAR-Γ GENE IN THE GENESIS OF THE GESTATIONAL WEIGHT GAIN.
Ostafiichuk S; Henyk N; Rossokha Z
Georgian Med News; 2018 Dec; (285):86-92. PubMed ID: 30702076
[TBL] [Abstract][Full Text] [Related]
12. COMT genotype and cognitive function: an 8-year longitudinal study in white and black elders.
Fiocco AJ; Lindquist K; Ferrell R; Li R; Simonsick EM; Nalls M; Harris TB; Yaffe K;
Neurology; 2010 Apr; 74(16):1296-302. PubMed ID: 20404311
[TBL] [Abstract][Full Text] [Related]
13. PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
Jermendy A; Körner A; Kovács M; Madácsy L; Cseh K
J Pediatr Endocrinol Metab; 2011; 24(1-2):55-9. PubMed ID: 21528816
[TBL] [Abstract][Full Text] [Related]
14. The PPAR-gamma Pro12Ala polymorphism associates with weight gain during GH-treatment in short children born small for gestational age.
de Kort SW; Hokken-Koelega AC
Eur J Endocrinol; 2010 Jan; 162(1):49-52. PubMed ID: 19808901
[TBL] [Abstract][Full Text] [Related]
15. The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women.
Rhee EJ; Oh KW; Yun EJ; Jung CH; Park CY; Lee WY; Oh ES; Baek KH; Kang MI; Park SW; Kim SW
Exp Mol Med; 2007 Dec; 39(6):696-704. PubMed ID: 18160840
[TBL] [Abstract][Full Text] [Related]
16. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia.
Yaffe K; Falvey C; Hamilton N; Schwartz AV; Simonsick EM; Satterfield S; Cauley JA; Rosano C; Launer LJ; Strotmeyer ES; Harris TB
Arch Neurol; 2012 Sep; 69(9):1170-5. PubMed ID: 22710333
[TBL] [Abstract][Full Text] [Related]
17. Gender-specific effect of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma-2 gene on obesity risk and leptin levels in a Tunisian population.
Ben Ali S; Ben Yahia F; Sediri Y; Kallel A; Ftouhi B; Feki M; Elasmi M; Haj-Taieb S; Souheil O; Sanhagi H; Slimane H; Jemaa R; Kaabachi N
Clin Biochem; 2009 Nov; 42(16-17):1642-7. PubMed ID: 19733160
[TBL] [Abstract][Full Text] [Related]
18. The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal study.
West NA; Haan MN; Morgenstern H
Neurobiol Aging; 2010 May; 31(5):741-6. PubMed ID: 18639367
[TBL] [Abstract][Full Text] [Related]
19. A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.
Danawati CW; Nagata M; Moriyama H; Hara K; Yasuda H; Nakayama M; Kotani R; Yamada K; Sakata M; Kurohara M; Wiyono P; Asdie H; Sakaue M; Taniguchi H; Yokono K
Diabetes Metab Res Rev; 2005; 21(5):465-9. PubMed ID: 15739197
[TBL] [Abstract][Full Text] [Related]
20. [Association of PPARgamma2 Pro12Ala polymorphism and cognitive dysfunction in hypertension patients].
Peng Y; Luo XJ; Chen XP; Li LX; Wan LY; He S; Chen XN; Wu K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):1034-8. PubMed ID: 21265110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
